Literature DB >> 6586250

The pharmacokinetics of new cephalosporins: significance in clinical practice.

H C Neu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6586250      PMCID: PMC1911771     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN: 0028-7091


× No keyword cloud information.
  16 in total

1.  Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels.

Authors:  R Wise; S Baker; R Livingston
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

2.  Cefotaxime in bronchopulmonary infections--a clinical and pharmacological study.

Authors:  H Lode; B Kemmerich; G Gruhlke; G Dzwillo; P Koeppe; I Wagner
Journal:  J Antimicrob Chemother       Date:  1980-09       Impact factor: 5.790

3.  Postantibiotic suppression of bacterial growth.

Authors:  R W Bundtzen; A U Gerber; D L Cohn; W A Craig
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

Review 4.  The new beta-lactamase-stable cephalosporins.

Authors:  H C Neu
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

5.  The inhibitory quotient. A method for interpreting minimum inhibitory concentration data.

Authors:  P D Ellner; H C Neu
Journal:  JAMA       Date:  1981-10-02       Impact factor: 56.272

6.  Levels of cefotaxime in body fluids and tissues: a review.

Authors:  W J Novick
Journal:  Rev Infect Dis       Date:  1982 Sep-Oct

7.  Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli.

Authors:  L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

8.  Cefotaxime kinetics after intravenous and intramuscular injection of single and multiple doses.

Authors:  H C Neu; P Aswapokee; K P Fu; I Ho; C Matthijssen
Journal:  Clin Pharmacol Ther       Date:  1980-05       Impact factor: 6.875

Review 9.  Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function.

Authors:  R A Greenfield; A U Gerber; W A Craig
Journal:  Rev Infect Dis       Date:  1983 Mar-Apr

Review 10.  A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic.

Authors:  H C Neu
Journal:  Ther Drug Monit       Date:  1981       Impact factor: 3.681

View more
  4 in total

Review 1.  Pharmacokinetic properties of the cephalosporins.

Authors:  T Bergan
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 2.  Cephalosporins--cefotaxime 10 years later, a major drug with continued use.

Authors:  H C Neu
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 3.  Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

4.  Cefotaxime diffusion into cerebrospinal fluid of children with meningitis.

Authors:  B I Asmar; M C Thirumoorthi; J A Buckley; D M Kobos; A S Dajani
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.